Evidence map›Paper›PMID 31270324›Full record

ArticleNature communications2019

E2F4 regulates transcriptional activation in mouse embryonic stem cells independently of the RB family.

Jenny Hsu, Julia Arand, Andrea Chaikovsky, Nancie A Mooney, Janos Demeter, Caileen M Brison, Romane Oliverio, Hannes Vogel, Seth M Rubin, Peter K Jackson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 85 citations in OpenAlex.

  1. Resistance of E2F4DN to p38Scientific reports · 2026
    Article
  2. Dysregulation of Aurora Kinases andCurrent issues in molecular biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Detection by Single-Cell RNA Sequencing of Virally Mediated Skin Diseases.JID innovations : skin science from molecules to population health · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jenny HsuDepartment of Pediatrics, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Julia ArandDepartment of Pediatrics, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0002-2357-1119
Andrea ChaikovskyDepartment of Pediatrics, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Nancie A MooneyBaxter Laboratory, Department of Microbiology & Immunology, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Janos DemeterBaxter Laboratory, Department of Microbiology & Immunology, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Caileen M BrisonDepartment of Chemistry and Biochemistry, University of California, 1156 High Street, Santa Cruz, CA, 95064, USA.
Romane OliverioDepartment of Pediatrics, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Hannes VogelDepartment of Pediatrics, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Seth M RubinDepartment of Chemistry and Biochemistry, University of California, 1156 High Street, Santa Cruz, CA, 95064, USA.
Peter K JacksonBaxter Laboratory, Department of Microbiology & Immunology, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA.
Julien SageDepartment of Pediatrics, 300 Pasteur Drive, Stanford University, Stanford, CA, 94305, USA. julsage@stanford.edu.ORCID http://orcid.org/0000-0002-8928-9968
Stanford University · USUniversity of California, Santa Cruz · US

Funding

Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
The RB pathway in liver cancerR01CA114102 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2006 to 2016
$2.9M
Molecular basis of tumor suppression by Cdk4/6 inhibitionR01CA228413 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI RUBIN, SETH MICHAEL, SAGE, JULIEN · 2019 to 2023
$1.8M
High Throughput DNA Sequencer UpgradeS10OD018220 · OD · STANFORD UNIVERSITY · PI COLLER, JOHN · 2014 to 2014
$596k
A novel role for E2F4 as a transcriptional activator and a cell cycle driverF31CA196220 · NCI · STANFORD UNIVERSITY · PI HSU, JENNY · 2015 to 2016
$69k
NCI NIH HHS F31 CA196220NCI NIH HHS R01 CA114102NCI NIH HHS R01 CA228413NCI NIH HHS T32 CA009302NIGMS NIH HHS T32 GM007790NIH HHS S10 OD018220
6 · The paper itself

Abstract

E2F transcription factors are central regulators of cell division and cell fate decisions. E2F4 often represents the predominant E2F activity in cells. E2F4 is a transcriptional repressor implicated in cell cycle arrest and whose repressive activity depends on its interaction with members of the RB family. Here we show that E2F4 is important for the proliferation and the survival of mouse embryonic stem cells. In these cells, E2F4 acts in part as a transcriptional activator that promotes the expression of cell cycle genes. This role for E2F4 is independent of the RB family. Furthermore, E2F4 functionally interacts with chromatin regulators associated with gene activation and we observed decreased histone acetylation at the promoters of cell cycle genes and E2F targets upon loss of E2F4 in RB family-mutant cells. Taken together, our findings uncover a non-canonical role for E2F4 that provide insights into the biology of rapidly dividing cells.

Indexed as

Transcriptional ActivationAnimalsCell CycleCell DivisionE2F4 Transcription FactorGene Expression Regulation, DevelopmentalMiceMouse Embryonic Stem CellsMultigene FamilyRetinoblastoma ProteinE2f4 protein, mouseE2F4 Transcription FactorRetinoblastoma Protein

Identifiers

PMID31270324
PMCPMC6610666
OpenAlexW2954288393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.